Education

Increased pressure on embryo may impact facial development: Study

An embryo in the womb experiencing increased pressure due to fluids may impact facial development, including the risk of malformations, a new research has found.

The study found that an increase in pressure exerted by still fluids, or hydrostatic pressure, sensed by the embryo can hinder the healthy development of facial features. Researchers at the University College, London, UK, said differences in pressure bears the risk of facial malformations.

The researchers performed their analyses in mice and frog embryos, and in lab-grown structures made of human stem cells. Human stem cells cannot perform specific functions to begin with but, with time, self-renew and have the potential to become specialised cells such as those in muscles, blood or brain. These cells are needed for tissue maintenance and also repairs following an injury.

“When an organism is experiencing a change in pressure, all the cells — including the embryo inside the mother — are able to sense it,” said Roberto Mayor, professor of developmental and cellular neurobiology at the University College, London, and lead author of the study, which has been published in the Nature Cell Biology journal.

“Our findings suggest that facial malformations could be influenced not only by genetics but by physical cues in the womb such as pressure,” he said.

Medlarge

Recent Posts

AIIMS Doctor perform congenital lung malformation rare surgery on 4-month child

Doctors at AIIMS Delhi have successfully performed a rare and technically demanding lung-preserving surgery on…

1 week ago

22-year-old woman undergoes for decade long facial tumour through Scarless Surgery

Sharda Hospital successfully performed a rare scarless surgery to remove a massive benign facial tumor…

3 weeks ago

29-year-old woman undergoes breast reconstruction for childhood burn deformity

A 29-year-old woman with a severe post-burn deformity of the left chest and breast, resulting…

3 weeks ago

Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test

Zydus Lifesciences with Guardant Health, having an agreement to make the Shield™ Multi-Cancer Detection (MCD)…

3 weeks ago

Why India needs uniform strategy for equitable access to Cancer treatment, experts explain

In the backdrop of observation that India may emerge as the Cancer Capital of the…

3 weeks ago

Centre bans sale of Cough syrups without valid prescription

The Centre has amended the Drugs rule, omitting the word “Syrup” from Schedule K, the…

1 month ago